---
figid: PMC4854877__fcell-04-00037-g0002
figtitle: Dynamic angiogenic signaling balance and angiogenic switch
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC4854877
filename: fcell-04-00037-g0002.jpg
figlink: /pmc/articles/PMC4854877/figure/F2/
number: F2
caption: Dynamic angiogenic signaling balance and angiogenic switch. VEGF, as an important
  angiogenic cytokine, is critical for proangiogenesis, and proarteriogenesis via
  activating VEGF receptor 2. VEGF signaling via VEGF receptor 2 can activate PKD-1
  pathway via PLCγ1 to stimulate MAPK/Erk1/2 and PI3K/Akt activation. However, oncogenes,
  such as ras and myc or tumor suppressor gene p53 down-regulate or up-regulate TSP-1
  expression, and affect TSP-1 interaction with the CD36 receptor, altering the activities
  of Fyn, p38/JNK, and PI3K/Akt kinases. This interaction may produce disturbances
  in the dynamic signaling balance between angiogenesis stimulators and inhibitors.
  The dominant signaling will determine the angiogenic switch. LPA also activates
  PKD-1 signaling to suppress CD36 transcription to tip the signaling balance to VEGF-mediated
  proangiogenic and proarteriogenic responses. Inhibition of CD36 expression and its
  anti-angiogenic signaling can prime VEGF signaling for turning on the proangiogenic
  and proarteriogenic switch for angiogenesis and arteriogenesis.
papertitle: Protein Kinase D1 Signaling in Angiogenic Gene Expression and VEGF-Mediated
  Angiogenesis.
reftext: Bin Ren. Front Cell Dev Biol. 2016;4:37.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9216979
figid_alias: PMC4854877__F2
figtype: Figure
redirect_from: /figures/PMC4854877__F2
ndex: a569984b-df06-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4854877__fcell-04-00037-g0002.html
  '@type': Dataset
  description: Dynamic angiogenic signaling balance and angiogenic switch. VEGF, as
    an important angiogenic cytokine, is critical for proangiogenesis, and proarteriogenesis
    via activating VEGF receptor 2. VEGF signaling via VEGF receptor 2 can activate
    PKD-1 pathway via PLCγ1 to stimulate MAPK/Erk1/2 and PI3K/Akt activation. However,
    oncogenes, such as ras and myc or tumor suppressor gene p53 down-regulate or up-regulate
    TSP-1 expression, and affect TSP-1 interaction with the CD36 receptor, altering
    the activities of Fyn, p38/JNK, and PI3K/Akt kinases. This interaction may produce
    disturbances in the dynamic signaling balance between angiogenesis stimulators
    and inhibitors. The dominant signaling will determine the angiogenic switch. LPA
    also activates PKD-1 signaling to suppress CD36 transcription to tip the signaling
    balance to VEGF-mediated proangiogenic and proarteriogenic responses. Inhibition
    of CD36 expression and its anti-angiogenic signaling can prime VEGF signaling
    for turning on the proangiogenic and proarteriogenic switch for angiogenesis and
    arteriogenesis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - THBS1
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - CD36
  - KDR
  - PLCG1
  - FYN
  - PKD1
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAPK3
  - LPA
  - LPAR3
  - LPAR1
  - FZD4
  - NMUR1
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
---
